T3	Participants 282 357	Thirty-two patients undergoing six courses of paclitaxel-based chemotherapy
T1	Participants 11 21	paclitaxel
T2	Participants 233 243	paclitaxel
T4	Participants 1365 1451	patients with cancer from the occurrence of paclitaxel-induced peripheral nerve damage
